|

Micronutrients in Health and Disease
Table 3:
Mineral Functions, Deficiency Diseases, Toxicity Symptoms,
and Dietary Reference
Intakes*
|
Mineral |
Biochemical
Role/Function |
Deficiency
Symptoms |
Toxicity Symptoms |
Recommended
Dietary Allowance or AI (*) |
Calcium
(Ca)
|
Component of teeth and bones; mediates
vascular contraction and vaso–dilation, muscle contraction,
nerve transmission, and glandular secretion |
Reduced bone mass and osteoporosis |
Hypercalcemia; increased risk
for kidney stones (with supplements); milk–alkali syndrome;
possible increase in risk for prostate cancer (see Prostate
Cancer chapter) |
Adults: (*)
Ages 19–50: 1,000
mg
Age 51+: 1,200
mg
Infants/children: (*)
0–6 months: 210
mg
7–12months: 270
mg
1–3 years: 500
mg
4–8 years: 800
mg
9–18 years: 1,300
mg
Pregnancy/lactation:(*)
Age <18: 1,300mg
Age
19+: 1,000
mg |
Phosphorus
(P)
|
Component of most biological membranes
and nucleotides and nucleic acids; buffering of acid or alkali
excesses; temporary storage and transfer of the energy derived
from metabolic fuels; activation of many catalytic proteins
through phosphorylation |
Anorexia, anemia, muscle
weakness, bone pain, rickets and osteomalacia, general debility;
may be seen in persons recovering from alcoholic bouts; in
diabetic keto–acidosis; in refeeding with calorie–rich sources
without paying attention to phosphorus needs; & with AL–containing
antacids |
Metastatic calcification,
skeletal porosity, interference
with calcium absorption |
Adults (ages 19+): 700
mg
Infants/children: (*)
0–6 months: 100
mg
7–12months: 275mg
1–3 years: 460
mg
4–8 years: 500
mg
9–18 years: 1,250
mg
Pregnancy/lactation:
Age <18: 1,250
mg
Age 19+: 700 mg |
Magnesium
(Mg) |
Required cofactor for over 300
enzymes, including ones involved in anaerobic and aerobic energy
generation, glycolysis, and oxidative phosphorylation; DNA
and RNA synthesis; activation of adenylate cyclase; sodium,
potassium–ATPase activity; has a calcium channel–blocking effect |
Hypocalcemia; neuro–muscular hyperexcitability & latent
tetany; insulin resistance and impaired insulin secretion |
GI disturbance (diarrhea, nausea,
abdominal cram–ping, paralytic ileus); more likely to occur
with impaired renal function |
Adults:
Ages 19–30
males: 400
mg
females: 310
mg
Ages 31+
males: 420 mg
females: 320 mg
Infants/children: (*)
0–6 months: 30 mg
7–12months: 75 mg
1–3 years: 80 mg
4–8 years: 130 mg
9–13 years: 240 mg
14–18 years: (males) 410 mg
(females) 360 mg
Pregnancy:
Ages <18: 400 mg
Ages 19–30: 350
mg
Ages 31–50: 360mg
Lactation:
Ages <18: 360 mg
Ages 19–30: 310
mg
Ages 31–50: 320 mg |
Source: Institute of Medicine. Dietary Reference Intakes for
Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington,
D.C.: National Academies Press, 1997.
* IOM did not set an RDA for vitamins in this age group. Instead,
an Adequate Intake (AI) is used. According to the Institute of Medicine, “The
AI is a recommended average daily nutrient intake level, based on
experimentally derived intake levels or approximations of observed
mean nutrient intake by a group (or groups) of apparently healthy
people that are assumed to be adequate. An AI is established when
there is insufficient scientific evidence to determine an Estimated
Average Requirement (EAR).”
Mineral |
Biochemical role/function |
Deficiency symptoms |
Toxicity symptoms |
Recommended Dietary Allowance
or AI (*) |
Potassium(K)
|
Neural transmission;
muscle contraction, vascular tone |
Cardiac arrhythmias; muscle weakness;
leg discomfort; extreme thirst; frequent urination; confusion;
glucose intolerance, increased blood pressure, increased salt
sensitivity, increased risk for kidney stones, increased bone
turnover |
Fatigue, weak–ness, tingling, numbness,
or other unusual sensations; paralysis, palpitations, difficulty
breathing; cardiac arrhythmias; GI distress |
Adults & children:
> 14 years of age: (*) 4,700 mg
Infants/children: (*)
0–6 months: 400
mg
7–12months: 700mg
1–3 years: 3,000
mg
4–8 years: 3,800
mg
9–13 years: 4,500
mg
Pregnancy:(*) 4,700
mg
Lactation:(*) 5,100
mg |
Sodium
(Na)
|
Maintenance of extra–cellular volume
and plasma osmolality; is an important determinant of the membrane
potential of cells and the active transport of molecules across
cell membranes |
Brain swelling, resulting in loss
of appetite, nausea, vomiting, headache, mental status changes
(confusion, irritability, fatigue, hallucinations); muscle
weakness, convulsions |
Elevated blood pressure; increased
risk for cardiovascular disease and stroke; neuro–logic
symptoms (confusion, coma, paralysis of the lung muscles) |
Adults: 19–50 years: (*) 1,500
mg
51–70 years: 1,300
mg
70+ years: 1,200
mg
Infants/children: (*)
0–6 months: 120
mg
7–12months: 370mg
1–3 years: 1,000
mg
4–8 years: 1,200
mg
9–18 years: 1,500
mg
Pregnancy:(*) 1,500
mg
Lactation:(*)2,300
mg |
Chloride
(Cl) |
Important component of gastric juice
as hydrochloric acid |
Hypochloremic metabolic alkalosis.
In infants, hypochloremia results in growth failure, lethargy,
irritability, anorexia, gastrointestinal symptoms, and weakness;
may also result in hypokalemia, metabolic alkalosis, hematuria,
hyper–aldosteronism, and increased plasma renin |
Dehydration, fluid loss, hyper–natremia |
Adults:
19–50 years:(*) 2,300
mg
51–70 years: 2,000mg
> 70 years: 1,800
mg
Infants/children: (*)
0–6 months: 180mg
7–12months: 570mg
1–3 years: 1,500mg
4–8 years: 1,900mg
9–18 years: 2,300mg
Pregnancy: (*) 2,300mg
Lactation:(*) 2,300mg |
Source: Institute of Medicine. Dietary Reference Intakes for
Water, Potassium, Sodium, Chloride, and Sulfate. Washington,
D.C.: National Academies Press, 2004.
Mineral |
Biochemical Role/Function |
Deficiency
Symptoms |
Toxicity Symptoms |
Recommended Dietary Allowance
or AI (*) |
Iron
|
Component of enzymes necessary
for oxidative metabolism; heme proteins (hemoglobin,
myoglobin, cytochromes); partici–
pates in electron transfer |
Impaired physical work performance,
develop–mental delay, cognitive impairment, anemia |
Fatigue, anorexia, dizziness, nausea,
vomiting, headache, weight loss, shortness of breath
|
Adults:
Men 19+ & women 51+: 8.0 mg
Women (age 19–50): 18.0 mg
Infants/children:
0–6 months:(*) 0.27 mg
7–12 months: 11,mg
1–3 years: 7,mg
4–8 years: 10 mg
9–13 years: 8 mg
14–18 years (boys): 11 mg
14–18 years (girls): 15 mg
Pregnancy: 27 mg
Lactation:
14–18 years: 10 mg
19–50 years: 9mg |
Zinc |
Component of enzymes (RNA polymerase,
alkaline phosphatase); structural role for some enzymes and
in protein folding; anti–oxidant function as part of zinc–copper
SOD |
Growth retardation, hair loss,
diarrhea, delayed sexual maturation and impotence, eye and
skin lesions, loss of appetite, delayed wound healing |
GI symptoms (epi–gastric pain, nausea,
vomiting, abdominal cramps, diarrhea); impaired immune response;
reduced copper status |
Adults (ages 19+):
Men: 11.0 mg
Women: 8.0 mg
Infants/children:
0–6 months: (*) 2 mg
7 months to 3 years: 3 mg
4–8 years: 5 mg
9–13 years: 8 mg
14–18 years (boys): 11 mg
14–18 years (girls): 9 mg
Pregnancy:
14 to 18 years: 12 mg
19+ years: 11 mg
Lactation:
< 18 years: 13 mg
19+ years: 12 mg
|
Copper |
Component of metallo–enzymes (oxidases;
eg, monoamine oxidase; lysyl oxidase used for collagen and
elastin production; cytochrome c oxidase; dopamine β mono–oxygenase);
part of zinc–copper SOD |
Defects in connective tissue; anemia;
immune and cardiac dysfunction |
GI symptoms (abdominal pain, nausea,
vomiting, cramps, diarrhea)
|
Adults (ages 19+): 900 µg
Infants/children: (*)
0–6 months:200 µg
7–12 months: 220 µg
1–3 years: 340 µg
4–8 years: 440 µg
9–13 years: 700 µg
14–18 years: 890 µg
Pregnancy: 1000 µg
Lactation: 1300 µg |
Chromium |
Potentiation of insulin action;
mobilize the glucose transporter, GLUT4, to the plasma membrane
(Mol Endocrinol. 2006;20:857–870); enhances tyrosine
phosphorylation of the insulin receptor (Biochemistry.2005;44:8167–8175) |
Rare; found in patients on TPN
prior to inclusion of Cr+3; symptoms included weight loss,
neuropathy, and impaired glucose tolerance |
None for Cr+3; Cr+6 is a known carcinogen
when inhaled, and oral ingestion (20 mg/l) causes GI symptoms
(abdominal pain, nausea, vomiting, diarrhea) |
Adults:
Men (age 19–50): 35 µg
Women (age 19–50): 25 µg
Males (age 50+): 30 µg
Females (age 50+): 20 µg
Infants/children: (*)
0–6 months: 0.2 µg
7–12 months: 5.5 µg
1–3 years: 11 µg
4–8 years: 15 µg
9–13 years (males): 25 µg
9–13 years (females): 21 µg
14–18 years (males): 35 µg
14–18 years (females): 24 µg
Pregnancy: 30 µg
Lactation: 45 µg |
Sources: Institute of Medicine. Dietary Reference Intakes for
Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine,
Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington,
D.C.: National Academies Press, 2000;
National Institutes of Health, Office of Dietary Supplements Web
site (http://dietary–supplements.info.nih.gov/)
Mineral |
Biochemical role/function |
Deficiency symptoms |
Toxicity symptoms |
Recommended Dietary Allowance
or AI (*) |
|
Selenium
|
Defense against oxidative stress,
regulation of thyroid hormone action, and regulation of the
redox status of vitamin C and other molecules, through
selenoproteins; eg, oxidant defense enzymes like glutathione
peroxidase; iodothyronine deiodinases |
Keshan disease (cardiomyopathy
in pediatric population); skeletal muscle disorders manifested
by muscle pain, fatigue, proximal weakness, and serum creatine
kinase (CK) elevation (Muscle Nerve.2003;27:662–668) |
Selenosis (gastrointestinal
upset, hair loss, white blotchy nails, garlic breath odor,
fatigue, irritability, and mild nerve damage); hair and nail
brittleness and loss
|
Adults (ages 19+): 55 µg
Infants/children: (*)
0–6 months: 15 µg
7–12 months: 20 µg
1–3 years: 20 µg
4–8 years: 30 µg
9–13 years: 40 µg
14–18 years: 55 µg
Pregnancy: 60 µg
Lactation: 70 µg |
Iodine |
Component of the thyroid hormones
thyroxine (T4) and triiodothyronine (T3) |
Mental retardation, hypothyroidism,
goiter, cretinism, and varying degrees of other growth and
developmental abnormalities |
Burning of the mouth, throat, and
stomach, abdominal pain, fever, nausea, vomiting, diarrhea,
weak pulse, cardiac irritability, coma, cyanosis; thyroid enlarge–ment
(goiter) from increased TSH stimulation; increased risk of
thyroid papillary cancer; iodermia; hyperthyroidism |
Adults (ages 19+): 150 µg
Infants/children:
0–6 months:(*) 110 µg
7–12 months:(*) 130 µg
1–3 years: 90 µg
4–8 years: 90 µg
9–13 years: 120 µg
14–18 years: 150 µg
Pregnancy: 220 µg
Lactation: 290 µg |
Manganese |
Component of metallo–enzymes (arginase,
manganese superoxide dismutase, pyruvate carboxylase) |
Dermatitis, hypocholesterolemia |
Neurotoxicity
|
Adults (ages 19+): (*)
Men: 2.3 mg
Women: 1.8 mg
Infants/children: (*)
0–6 months: 3 µg
7–12 months: 0.6 mg
1–3 years: 1.2 mg
4–8 years: 1.5 mg
9–13 years (boys): 1.9 mg
9–18 years (girls): 1.6 mg
14–18 years (boys): 2.2 mg
Pregnancy: (*) 2 mg
Lactation: (*) 2.6 mg |
Molybdenum
(MO) |
Component of sulfite oxidase, xanthine
oxidase, aldehyde oxidase, enzymes involved in catabolism of
sulfur–containing amino acids, purines, and pyridines |
Rare; initially seen in patients
on TPN, before addition of MO to standard TPN regimes; resulted
in tachycardia, headache, night blindness, low serum uric acid |
Reproductive effects as
observed in animal studies;
with occupational exposure, hyper–uricemia, and gout symptoms |
Adults (ages 19+): 45 µg
Infants/children: (*)
0–6 months: 2 µg
7–12 months: 3 µg
1–3 years: 17 µg
4–8 years: 22 µg
9–13 years: 34 µg
14–18 years (males): 43 µg
Pregnancy/lactation: 50 µg |
Sources: Institute of Medicine. Dietary Reference Intakes for
Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine,
Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington,
D.C.: National Academies Press, 2000;
National Institutes of Health, Office of Dietary Supplements Web
site (http://dietary–supplements.info.nih.gov/)
|